Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs NRG Energy Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while NRG Energy Inc trades at $100.16 (market cap $22.53B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and NRG Energy Inc pays the higher dividend (1.77%). Which is the better fit depends on your goals.
| GEHC | NRG | |
|---|---|---|
Market Cap | $31.07B | $22.53B |
Volume | 3,443,020 | 2,965,287 |
Sector | Health | Utilities |
52-Week High | $88.16 | $184.03 |
52-Week Low | $59.48 | $95.23 |
Enterprise Value | $39.53B | $46.49B |
Dividend Yield | 0.23% | 1.77% |
Typical Hold Time | — | 63 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
NRG Energy trades at $100.85, down 5.19% on the day amid mixed earnings results, with recent Q1 and Q2 2026 EPS misses. The stock shows neutral technical signals with bearish moving averages, while fundamentals reflect strong revenue growth to $30.71B in 2025 and a solid ROE of 26.77%, though net margins are thin at 2.56%. Recent news highlights a major 1.2 GW Texas data-center power project as a growth driver.
Outlook is cautiously optimistic given analyst consensus favoring Buy (70.37%) and a $202.90 price target, implying significant upside. Key risks include execution on large capex projects, rising debt-to-asset ratio (56.42% in 2025), and competitive pressures in utilities. The stock offers value with a low P/S of 0.66 but requires monitoring of earnings consistency and leverage trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
